Clorox (NYSE:CLX) PT Lowered to $151.00

Clorox (NYSE:CLX) had its price objective reduced by Deutsche Bank Aktiengesellschaft from $155.00 to $151.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target would suggest a potential upside of 6.17% from the company’s current price.

Several other analysts also recently issued reports on CLX. Barclays decreased their price objective on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a research note on Wednesday, April 10th. DA Davidson reissued a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a research note on Monday, February 5th. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a research note on Thursday, January 18th. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a research note on Tuesday, March 26th. Finally, Citigroup decreased their price target on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a research note on Tuesday. Four analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to MarketBeat.com, Clorox has an average rating of “Hold” and a consensus target price of $148.63.

Clorox Price Performance

CLX stock traded down $0.25 during trading on Wednesday, reaching $142.23. The company’s stock had a trading volume of 476,977 shares, compared to its average volume of 1,204,311. The company has a market capitalization of $17.65 billion, a P/E ratio of 225.51, a price-to-earnings-growth ratio of 2.19 and a beta of 0.43. The company’s fifty day moving average is $150.67 and its 200-day moving average is $141.68. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. Clorox has a 1 year low of $114.68 and a 1 year high of $178.21.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $1.08 by $1.08. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm’s revenue was up 16.0% on a year-over-year basis. During the same quarter last year, the business posted $0.98 earnings per share. On average, research analysts expect that Clorox will post 5.52 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Clorox

Large investors have recently made changes to their positions in the stock. Tyler Stone Wealth Management purchased a new stake in shares of Clorox during the second quarter valued at $25,000. O Dell Group LLC purchased a new stake in shares of Clorox during the fourth quarter valued at $28,000. Fortitude Family Office LLC purchased a new stake in shares of Clorox during the fourth quarter valued at $29,000. Northwest Financial Advisors purchased a new stake in shares of Clorox during the fourth quarter valued at $29,000. Finally, Core Wealth Advisors Inc. purchased a new stake in shares of Clorox during the fourth quarter valued at $29,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.